Compugen (CGEN) Tops Q1 EPS by 3c

Compugen (NASDAQ: CGEN) reported Q1 EPS of ($0.08), $0.03 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $2.56 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus